The store will not work correctly when cookies are disabled.
(E)-2-((1H-pyrrolo[2,3-b]pyridin-3-yl)methylene)-2,3-dihydro-1H-inden-1-one
ID: ALA4642750
PubChem CID: 156017134
Max Phase: Preclinical
Molecular Formula: C17H12N2O
Molecular Weight: 260.30
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1/C(=C/c2c[nH]c3ncccc23)Cc2ccccc21
Standard InChI: InChI=1S/C17H12N2O/c20-16-12(8-11-4-1-2-5-14(11)16)9-13-10-19-17-15(13)6-3-7-18-17/h1-7,9-10H,8H2,(H,18,19)/b12-9+
Standard InChI Key: YMQJPFROPZPOLP-FMIVXFBMSA-N
Molfile:
RDKit 2D
20 23 0 0 0 0 0 0 0 0999 V2000
14.2375 -20.8590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2364 -21.6785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9444 -22.0875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9426 -20.4501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6513 -20.8554 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6515 -21.6786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4345 -21.9327 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.9182 -21.2666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4341 -20.6008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6863 -19.8236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4856 -19.6534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.0935 -20.1950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8182 -18.9018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6310 -18.9868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8007 -19.7842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5746 -20.0344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1794 -19.4882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0052 -18.6887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2315 -18.4422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4087 -18.1947 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 15 1 0
14 13 1 0
13 11 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
13 20 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 260.30 | Molecular Weight (Monoisotopic): 260.0950 | AlogP: 3.39 | #Rotatable Bonds: 1 |
Polar Surface Area: 45.75 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 3.28 | CX LogP: 3.14 | CX LogD: 3.14 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.68 | Np Likeness Score: -0.52 |
References
1. Qhobosheane MA, Legoabe LJ, Josselin B, Bach S, Ruchaud S, Petzer JP, Beteck RM.. (2020) Synthesis and evaluation of 7-azaindole derivatives bearing benzocycloalkanone motifs as protein kinase inhibitors., 28 (11): [PMID:32284225] [10.1016/j.bmc.2020.115468] |